Relationship between nitric oxide production and choroidal blood flow

Journal of Ocular Pharmacology and Therapeutics

Volumn 19, Issue 3, 2003, Pages 247-253

  Xuan, Bo ^a   Xu, Xin Rong ^a   Chiou, George C Y ^a   Zhang, Yi Hua ^b   Peng, Si Xun ^b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYL 3 [3 METHOXY 2 PROPOXY 5 [4 (3,4,5 TRIMETHOXYPHENYL) 1,3 DITHIOLAN 2 YL]PHENYL]THIOUREA; 1,3 DITHIOLANE DERIVATIVE; NITRIC OXIDE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG; ZX 4; ZX 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHOROID; CILIARY BODY; CONTROLLED STUDY; DRUG INSTILLATION; EYE BLOOD FLOW; IN VITRO STUDY; IN VIVO STUDY; IRIS BLOOD VESSEL; ISOMER; NONHUMAN; RABBIT; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

EID: 0037709917     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076803321908365     Document Type: Article

References (15)

1. Ignarro L. Nitric oxide as a communicating signal in vascular and neuronal cells. Nitric Oxide, Principles and Actions. Lancaster J. Ed. pp 111-137 Academic Press, New York 1996.
2. Dawson V. L. and Dawson T. M. Physiological and toxicological actions of nitric oxide in the CNS. Nitric Oxide, Biochem. Molecular Biology and Therapeutics Implications Ignarro L. and Murad F Ed. pp 323-342 Academic Press, New York 1995.
3. Baer JA, Booth BP and Fung HL. Nitric oxide donors: Biochemical Pharmacology and Therapeutics. Nitric oxide, Biochem, Molecular Biology and Therapeutic Implications. Ignarro L and Murad F. Ed. pp 361-381 Academic Press, New York 1995.
4. Chiou, GCY. Review: Effects of nitric oxide on eye disease and their treatment. J. Ocular Pharmacol. Ther. 17:189-198 2001.
5. Xuan B. Wang T., Chiou, G.C.Y. Dalinger, I., Shkineva, T.K. and Shevelev, S.A. Effects of N-nitropyrazoles on ocular blood flow in rabbit eyes and retinal function recovery after ischemic insult in rat eye. J. Ocular Pharmacol. Ther. 17:505-515 2001.
6. Xuan B., Wang, T., Chiou, G.C.Y., Dalinger, I., Shkineva, T.K. and Shevelev, S.A. Effects of nitropyrazoles and c-nitroazoles on ocular blood flow and retinal function recovery after ischemic insult. Acta Pharmacol. Sinica 23:705-712 2002.
7. Beauregard, C., Brandt, P.C., and Chiou, G.C.Y. Nitric oxide and cyclic GMP-medicated protein secretion from cultured lacrimal gland acinar cells. J. Ocul. Pharmacol. Ther. 18:429-443, 2002.
8. Leibowitz, H.M., Krueger, D.E., Maunder, L.R., Milton, R.C., Kini, M.M., Kahn, H.A., Nickerson, R.J., Pool, J., Colton, T.L., Ganley, J.P., Loewenstein, J.I., and Dawber, T.R. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv. Ophthalmol. 24(Suppl):335-610, 1980.
9. Kahn, H.A., Leibowitz, H.M., Ganley, J.P., Kini, M.M., Colton, T., Nickerson, R.S., and Dawber, T.R. The Framingham eye study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham heart study. Am. J. Epidemiol. 106:33-41, 1977.
10. La Cour, M., Kiilgaard, J.F., and Nissan, M.H. Aged-related macular degeneration. Epidemology and optimal treatment. Drugs Aging 19(2):101-133, 2002.
11. Treatment of AMD with Photodynamic Therapy (TAP) study group. Verteporfin Therapy of subfoveal choroidal neovascularization in patients. Arch Ophthalmol. 120:1447-1454 2002.
12. Hamalaine, K.M., Kananen, K., Auriola, S., Kontturi, K., and Urtti, A. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest. Ophthalmol. Vis. Sci. 38:627-634 1997.
13. Schoenwald, R.D., Deshpande, G.S., Rethwisch, D.G. and Barfknecht, C.F. Penetration into the anterior chamber via the conjunctival/scleral pathway. J. Ocular Pharmacol. Ther. 13:41-59, 1997.
14. Geroski, D.H. and Edelhauser, H.F. Transscleral drug delivery for posterior segment disease. Adv. Drug Deliv. Rev. 52:37-48, 2001.
15. Ambati, J., Canakis, C.S., Miller, J.W., Gragoudas, E.S., Edwards, A. Weissgold, D.J., Kim, I., Delori, F.C., and Adamis, A.P. Diffusion of high molecular weight compounds through sclera. Invest. Ophthalmol. Vis. Sci. 41:1181-1185 2000.